Skip to main content
. 2022 Mar 1;26(2):143–150. doi: 10.4103/jisp.jisp_149_21

Table 5a.

Intergroup comparison of the change in salivary calprotectin from baseline to 8 weeks posttreatment

Parameter Study groups n Mean±SD ANOVA

F P
Salivary calprotectin A1 16 1.17±1.08 12.74 <0.001*
A2 14 1.62±1.01
B1 14 6.54±2.90
B2 16 7.99±6.63

*Value of P is considered statistically significant P<0.05. ANOVA – Analysis of variance; P – Probability; n – Number of participants; F – Fisher in ANOVA test; SD – Standard deviation; A1 – Patients with periodontitis receiving scaling and root planing; A2 – Patients with periodontitis receiving scaling and root planing as an adjunct to low-level laser therapy; B1 – Patients with periodontitis associated with type 2 diabetes mellitus receiving scaling and root planing; B2 – Patients with periodontitis associated with type 2 diabetes mellitus receiving scaling and root planing as an adjunct to low-level laser therapy